on Eckert & Ziegler Strahlen- Und Medizintechnik AG (isin : DE0005659700)
Eckert & Ziegler: Spin-off of Pentixapharm AG Registered
Berlin, 2 October 2024. Eckert & Ziegler SE announced that the spin-off resolution approved at the Annual General Meeting on 26 June 2024 has been entered in the commercial register of the Charlottenburg District Court. With this, the spin-off of Pentixapharm AG became legally effective. Accordingly, all shares in Pentixapharm AG held by Eckert & Ziegler have been transferred to Pentixapharm Holding AG.
In return, Eckert & Ziegler shareholders will receive Pentixapharm Holding AG shares at a 1:1 ratio. Their entitlement will be based on the number of Eckert & Ziegler shares held after the close of trading today. All shares created through the spin-off are expected to be admitted to Frankfurt Stock Exchange’s Prime Standard segment on 2 October 2024.
Initial trading of Pentixapharm Holding AG shares is scheduled for 3 October 2024. On the same day, the listing of Eckert & Ziegler SE shares ‘ex spin-off’ is planned. The deposit-side posting of Pentixapharm Holding shares to securities accounts of Eckert & Ziegler shareholders is expected on 7 October 2024.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Eckert & Ziegler Strahlen- Und Medizintechnik AG news